NMTech

NMTech (Nanomaterial Technologies) is a specialty pharmaceutical and drug delivery company that utilizes its proprietary Nano-Active technology platform to enhance the bioavailability and performance of poorly water-soluble drugs. The company's unique "bottom-up" nanotechnology process creates stable drug nanoparticles with high loading capacity, allowing for improved therapeutic profiles, lower dosages, and reduced side effects. NMTech focuses on reformulating established small molecule therapeutics into superior versions, primarily targeting the 505(b)(2) regulatory pathway. Its pipeline includes nano-formulations for cardiovascular, oncological, and inflammatory conditions, developed both internally and through strategic partnerships with global pharmaceutical firms. The company operates as a technology provider and collaborator, leveraging its platform to optimize drug delivery across various therapeutic areas.